First‐Line Marshall Plan Approach in Persistent Atrial Fibrillation: A Prospective Single‐Center Cohort Study.

Background: Different ablation strategies have been developed for persistent atrial fibrillation (PeAF), but early management is still controversial. In the clinical setting of PeAF, the safety and efficacy of early Marshall plan have not yet been fully studied. Objectives: Our prospective cohort st...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 36; no. 6; pp. 1244 - 1253
Autores principales: Carmaux, Antoine, Yvorel, Cedric, Benali, Karim, Romeyer, Cécile, Mohammed, Rayan, Vovor, Jean Michel, Da Costa, Antoine
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Jun2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186460406&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 186460406
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: Jun2025
      vid: 36
      iid: 6
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        186460406
        183939082
        186460406
        186460406
        10.1111/jce.16650
        186460406
      ppf: 1244
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: First‐Line Marshall Plan Approach in Persistent Atrial Fibrillation: A Prospective Single‐Center Cohort Study.
      aug:
        au:
          Carmaux, Antoine
          Yvorel, Cedric
          Benali, Karim
          Romeyer, Cécile
          Mohammed, Rayan
          Vovor, Jean Michel
          Da Costa, Antoine
        affil: Department of Cardiology, Jean Monnet University, Saint‐Etienne, France
      sug:
        subj:
          Atrial Fibrillation Surgery
          Catheter Ablation Methods
          Heart Atrium, Left
          Pulmonary Veins Surgery
          Treatment Outcomes Evaluation
          Patient Safety Evaluation
          Recurrence Risk Factors
          Risk Assessment
          Catheter Ablation Adverse Effects
          Recurrence Prevention and Control
          Human
          Male
          Female
          Prospective Studies
          Pilot Studies
          Descriptive Statistics
          Vasodilation
          Atrial Flutter
          Ventricular Ejection Fraction
          Male
          Female
      ab: Background: Different ablation strategies have been developed for persistent atrial fibrillation (PeAF), but early management is still controversial. In the clinical setting of PeAF, the safety and efficacy of early Marshall plan have not yet been fully studied. Objectives: Our prospective cohort study sought to: (1) assess the safety and feasibility of the thermal Marshall plan (MPA) approach as a first‐line therapy in PeAF patients; (2) evaluate its long‐term sinus rhythm maintenance efficacy; (3) identify the long‐term predictive factors of AF recurrence in PeAF patients after MPA approach. Methods and Results: Between January 2020 and December 2023, 118 PeAF patients were selected for first intent Marshall plan ablation (MPA). Marshall vein failure occurred in 9/118 patients (7.6%). Accordingly, 109 patients who underwent MPA as first‐line therapy were included. After the blanking period of 3 months, 62/109 patients were in sinus rhythm (SR) (57%), 33/109 were in AF (30.2%), 8/109 were in left atrial flutter (AFL) (7.3%), and six were in right AFL (5.5%). Re‐ablation was performed in 4/33 patients (12.1%) and cardioversion in 29/33 (87.9%) for patients in AF at 3 months after healing. All patients in AFL at 3 months were re‐ablated and all recovered SR. At 12 months postablation, two patients were lost to follow‐up (1.8%), 94/107 (87.8%) were in SR and 13/107 had AF recurrence (12.2%). At 21 ± 11 months postablation, 81/107 (75.7%) were in SR at the last control, and 26/107 (24.3%) had AF recurrence. The ablation procedure ratio was 1.17 (109 primo ablation, 18 re‐ablation). The only predictive factors of late AF recurrence after first‐line PeAF MPA were both left atrial dilatation and low left ventricular ejection fraction (LVEF). Conclusions: This real‐life prospective cohort study showed that de novo MPA in PeAF is feasible, relatively safe, and associated with a high rate of freedom from arrhythmia recurrence during long‐term follow‐up. The percentage of patients remaining in SR during long‐term follow‐up was close to 76%. The only predictive MPA failure factors were both left atrial dilatation and low LVEF.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N